Dermatomyositis Global Clinical Trials Review, H2, 2016 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Dermatomyositis Global Clinical Trials Review, H2, 2016" clinical trials to their offering.

Dermatomyositis Global Clinical Trials Review, H2, 2016

Summary

The author's clinical trial report, Dermatomyositis Global Clinical Trials Review, H2, 2016" provides an overview of Dermatomyositis clinical trials scenario. This report provides top line data relating to the clinical trials on Dermatomyositis.

The report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). The Clinical Trial Reports are generated using the author's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Key Topics Covered:

List of Tables & Figures

Report Guidance

Clinical Trials by Region

Clinical Trials and Average Enrollment by Country

Top Countries Contributing to Clinical Trials in Asia-Pacific

Top Five Countries Contributing to Clinical Trials in Europe

Top Countries Contributing to Clinical Trials in North America

Top Countries Contributing to Clinical Trials in Middle East and Africa

Top Countries Contributing to Clinical Trials in Central and South America

Clinical Trials by G7 Countries: Proportion of Dermatomyositis to Musculoskeletal Disorders Clinical Trials

Clinical Trials by Phase in G7 Countries

Clinical Trials in G7 Countries by Trial Status

Clinical Trials by E7 Countries: Proportion of Dermatomyositis to Musculoskeletal Disorders Clinical Trials

Clinical Trials by Phase in E7 Countries

Clinical Trials in E7 Countries by Trial Status

Clinical Trials by Phase

In Progress Trials by Phase

Clinical Trials by Trial Status

Clinical Trials by End Point Status

Subjects Recruited Over a Period of Time

Clinical Trials by Sponsor Type

Prominent Sponsors

Top Companies Participating in Dermatomyositis Therapeutics Clinical Trials

Prominent Drugs

Clinical Trial Profile Snapshots

Appendix

Companies Mentioned

- Novartis AG

- AstraZeneca Plc

- Astellas Pharma Inc.

- Truffle Capital

- Octapharma AG

- Amgen Inc.

- Mallinckrodt Plc

- Idera Pharmaceuticals, Inc.

- F. Hoffmann-La Roche Ltd.

For more information about this clinical trials report visit http://www.researchandmarkets.com/research/5zdzbj/dermatomyositis

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Clinical Trials

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Clinical Trials